BioNexus Gene Lab (BGLC) Return on Equity (ROE) (2018 - 2026)
BioNexus Gene Lab (BGLC) Return on Equity (ROE) from Dec 31, 2018 to Mar 31, 2026. The TTM BioNexus Gene Lab (BGLC) Return on Equity (ROE) is -6.72%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual ROE
Quarterly ROE
Annual Return on Equity (ROE) change of BioNexus Gene Lab (BGLC)
| Year | Return on Equity (ROE) | Change |
|---|---|---|
| 2025 | -34.61% | +79.98% |
| 2024 | -19.23% | -29.37% |
| 2023 | -27.23% | +404.43% |
| 2022 | -5.40% | -151.67% |
| 2021 | 10.45% | -36.18% |
| 2020 | 16.37% | -173.32% |
| 2019 | -22.32% | -1230.95% |
| 2018 | 1.97% | N/A |